His laboratory is studying molecular and cellular regulators of normal mammary gland development and perturbations that give rise to hereditary and sporadic breast cancer. Current research is focused on characterising the mammary epithelial cell hierarchy (the progression from long-lived stem cells to progenitor cells to mature epithelial cells) and delineating key cell fate specification and survival genes in the mammary gland. His group has also generated patient derived xenograft (PDX) models that are being used in ‘proof-of-principle’ pre-clinical studies, aimed at transferring promising drugs to the clinic.
Professor Geoff Lindeman, BSc(Med) MB BS(Hons) PhD FRACP FAHMS FAA
Geoff Lindeman is Joint Head of the Stem Cells and Cancer Division at the Walter and Eliza Hall Institute (NHMRC Senior Principal Research Fellow). He is also a medical oncologist and Director of the Joint Peter Mac and Royal Melbourne Hospital Familial Cancer Centre in the Victorian Comprehensive Cancer Centre. He holds an honorary appointment as Professorial Fellow in the Department of Medicine, University of Melbourne. Lindeman leads the Centre for Translational Breast Cancer Research (TransBCR), enabled by a NHMRC Centre of Research Excellence grant.
Do you like this page?